Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
OTCMKTS:TRXDW

TransEnterix (TRXDW) Stock Price, News & Analysis

→ Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad)
Free TRXDW Stock Alerts
$0.0011
0.00 (0.00%)
(As of 05/17/2024 ET)
Compare
Today's Range
$0.0011
▼
$0.0011
50-Day Range
N/A
52-Week Range
$0.0011
▼
$0.0011
Volume
N/A
Average Volume
3,440 shs
Market Capitalization
$157,054.70
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsSEC Filings
TRXDW stock logo

About TransEnterix Stock (OTCMKTS:TRXDW)

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

TRXDW Stock Price History

TRXDW Stock News Headlines

February 9, 2024 | benzinga.com
Life Science Partners L P Synergy's Net Worth
January 30, 2024 | investing.com
Asensus Surgical Inc (ASXC)
January 21, 2024 | ca.finance.yahoo.com
TransEnterix, Inc. (TRXDW)
June 13, 2023 | finance.yahoo.com
Surgical Robots Global Market Report 2023
May 27, 2023 | fool.com
Asensus Surgical (NYSEMKT: ASXC)
February 26, 2023 | msn.com
Liberia - Two Ex-Soldiers Claim Massaquoi Was At Waterside, Ordered Killings, Rapes
October 18, 2022 | streetinsider.com
Asensus Surgical, Inc. To Present at The LD Micro Main Event XV - StreetInsider.com
September 24, 2022 | seekingalpha.com
ASXC Asensus Surgical, Inc.
September 21, 2022 | finance.yahoo.com
Orthopedic Surgical Robots Market is likely to Grow USD 24.22 Billion with Registering a CAGR of 18.1% by 2029, Size, Share, Growth, Emerging Trends, and Regional Overview - Yahoo Finance
September 21, 2022 | globenewswire.com
Orthopedic Surgical Robots Market is likely to Grow USD 24.22 Billion with Registering a CAGR of 18.1% by 2029, Size, Share, Growth, Emerging Trends, and Regional Overview - GlobeNewswire
September 9, 2022 | stockhouse.com
2022-09-09 | NYSEAM:ASXC | Press Release | Asensus Surgical Inc. - Stockhouse
September 2, 2022 | benzinga.com
With 17.40% CAGR, Surgical Robots Market Size to Worth US$ 26.69 billion by 2030 | Growth Plus Reports - Benzinga
August 16, 2022 | finance.yahoo.com
Spine Surgery Robots Market is Set to Exceed Valuation of USD 139.93 Million with Potential Growth Rate of 8.40% by 2029 | Analyzed by Size Share, Trends, Key Players & Future Growth Outlook - Yahoo Finance
August 9, 2022 | streetinsider.com
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022 - StreetInsider.com
June 13, 2022 | globenewswire.com
Collaborative Robots Market worth $1671 Million by 2028 with a CAGR of 15.2% - GlobeNewswire
April 14, 2022 | finance.yahoo.com
Bariatric Surgical Devices Market size worth $ 2223.84 Million, Globally, by 2028 at 9.29% CAGR: Verified Market Research® - Yahoo Finance
February 17, 2022 | finance.yahoo.com
Robotic Surgery Services Global Market Report 2022 - Yahoo Finance
February 15, 2022 | finance.yahoo.com
Surgical Robots Market Size & Share Report [2021-2026] | Market worth USD 6,875.1 Mn with 21.4% CAGR - Yahoo Finance
February 11, 2022 | businesswire.com
Global Medical Device Market Outlook 2022-2027: Demographic Drivers, Cultural Shifts and the Pandemic have Supercharged the Medical Device Market - ResearchAndMarkets.com - Business Wire
October 26, 2021 | finance.yahoo.com
Here's Why TransEnterix Rallied 47% in 2017
October 25, 2021 | prnewswire.com
Surgical Robots Market size worth $ 22.27 Billion, Globally, by 2028 at 17.60% CAGR: Verified Market Research® - PRNewswire
October 9, 2021 | fool.com
Is Intuitive Surgical a Buy on the Dip? - Motley Fool
August 13, 2021 | finance.yahoo.com
Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors - Yahoo Finance
August 4, 2021 | globenewswire.com
Medical Robots Market Research Report 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast - GlobeNewswire
August 4, 2021 | finance.yahoo.com
Medical Robots Market Research Report 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast - Yahoo Finance
See More Headlines

Company Calendar

Last Earnings
11/05/2020
Today
5/20/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRXDW
CUSIP
N/A
CIK
876378
Web
www.transenterix.com
Phone
+1-919-7658400
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($4.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-154,200,000.00
Net Margins
-2,149.15%
Pretax Margin
N/A
Return on Equity
-83.74%
Return on Assets
-64.94%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
3.24
Quick Ratio
2.30

Sales & Book Value

Annual Sales
$8.53 million
Price / Sales
0.02
Cash Flow
$0.00 per share
Price / Cash Flow
1.40
Book Value
$2.68 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
142,777,000
Free Float
N/A
Market Cap
$157,054.70
Optionable
Not Optionable
Beta
2.56

Key Executives

  • Mr. Todd M. Pope (Age 53)
    CEO, Pres & Director
  • Mr. Joseph P. Slattery (Age 53)
    Exec. VP, CFO & Principal Accounting Officer
  • Mr. Anthony Fernando (Age 46)
    COO, CTO & Exec. VP
  • Mr. Joshua B. Weingard (Age 45)
    Chief Legal Officer & Sec.
  • Dr. Stephanie M. Fitts Ph.D. (Age 52)
    VP of RA/QA, Clinical and Compliance

Key Competitors

View All Competitors

TRXDW Stock Analysis - Frequently Asked Questions

How have TRXDW shares performed in 2024?

TransEnterix's stock was trading at $0.05 at the start of the year. Since then, TRXDW shares have decreased by 97.8% and is now trading at $0.0011.
View the best growth stocks for 2024 here.

How were TransEnterix's earnings last quarter?

TransEnterix, Inc. (OTCMKTS:TRXDW) issued its earnings results on Thursday, November, 5th. The medical instruments supplier reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.11. The medical instruments supplier had revenue of $0.81 million for the quarter, compared to analysts' expectations of $0.73 million. TransEnterix had a negative trailing twelve-month return on equity of 83.74% and a negative net margin of 2,149.15%.

How do I buy shares of TransEnterix?

Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TRXDW) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Does this make you sick?
Allegiance Gold
Dems have chosen Biden replacement?
Paradigm Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest